Unlock complete market coverage with free stock recommendations, technical analysis, sector performance tracking, and strategic investment guidance updated daily.
Burning Rock Biotech Limited American Depositary Shares (BNR) is trading at $17.0 as of 2026-05-01, notching a 4.68% gain on the day amid mild positive sentiment across the broader biotech sector. This analysis outlines key technical levels, recent market context, and potential scenarios for BNR in upcoming trading sessions, with a focus on observed support and resistance thresholds that have shaped recent price action. As a developer of precision oncology diagnostics and therapeutics, BNR’s pri
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01 - Triple EMA
BNR - Stock Analysis
4421 Comments
1459 Likes
1
Lorrianne
Trusted Reader
2 hours ago
Execution at its finest.
👍 181
Reply
2
Corrina
Registered User
5 hours ago
As a beginner, I honestly could’ve used this a lot sooner.
👍 108
Reply
3
Abbigael
Experienced Member
1 day ago
Pullbacks in select sectors provide rotation opportunities.
👍 192
Reply
4
Mart
Registered User
1 day ago
I wish I had come across this sooner.
👍 149
Reply
5
Anaceli
Community Member
2 days ago
This feels like a test I already failed.
👍 90
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.